Search Browse Earnings

Astria Therapeutics, Inc. — SlamSEC

Astria Therapeutics, Inc.

Pharmaceutical Preparations·BOSTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$250,000

FY 2017

Adj. EBITDA

-$82.9M

-33164.4% margin

FY 2024

Net Income

-$72.9M

-29156.4% margin

FY 2024

EPS (Diluted)

-$2.42

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$175.5M

FY 2024

Total Debt

$5.0M

FY 2017

Net Cash

$170.6M

FY 2017

Enterprise Value

—

Debt / EBITDA

2.1x

FY 2017

EV / EBITDA

—

Employees

—